- Home
- BPMC vs GLBE Comparison
BPMC vs GLBE Comparison
Compare BPMC & GLBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- GLBE
- Stock Information
- Founded
- BPMC 2008
- GLBE 2013
- Country
- BPMC United States
- GLBE Israel
- Employees
- BPMC N/A
- GLBE N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- GLBE Computer Software: Prepackaged Software
- Sector
- BPMC Health Care
- GLBE Technology
- Exchange
- BPMC Nasdaq
- GLBE Nasdaq
- Market Cap
- BPMC 5.8B
- GLBE 6.5B
- IPO Year
- BPMC 2015
- GLBE 2021
- Fundamental
- Price
- BPMC $88.51
- GLBE $35.65
- Analyst Decision
- BPMC Buy
- GLBE Strong Buy
- Analyst Count
- BPMC 22
- GLBE 12
- Target Price
- BPMC $124.29
- GLBE $58.33
- AVG Volume (30 Days)
- BPMC 958.8K
- GLBE 1.8M
- Earning Date
- BPMC 05-01-2025
- GLBE 05-19-2025
- Dividend Yield
- BPMC N/A
- GLBE N/A
- EPS Growth
- BPMC N/A
- GLBE N/A
- EPS
- BPMC N/A
- GLBE N/A
- Revenue
- BPMC $508,824,000.00
- GLBE $752,764,000.00
- Revenue This Year
- BPMC $45.43
- GLBE $28.31
- Revenue Next Year
- BPMC $32.80
- GLBE $25.79
- P/E Ratio
- BPMC N/A
- GLBE N/A
- Revenue Growth
- BPMC 104.04
- GLBE 32.08
- 52 Week Low
- BPMC $80.68
- GLBE $28.11
- 52 Week High
- BPMC $121.90
- GLBE $63.69
- Technical
- Relative Strength Index (RSI)
- BPMC 43.04
- GLBE 31.59
- Support Level
- BPMC $86.99
- GLBE $35.67
- Resistance Level
- BPMC $93.04
- GLBE $40.02
- Average True Range (ATR)
- BPMC 3.36
- GLBE 1.74
- MACD
- BPMC 0.32
- GLBE 0.50
- Stochastic Oscillator
- BPMC 29.62
- GLBE 30.63
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About GLBE Global-E Online Ltd.
Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from, and, anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.